Lala M. Dunbar, MD, PhD

Administration	Basic Sciences	Clinical Sciences	Centers of Excellence
Admissions Alumni Affairs Community and Minority Health Education Computer Support Continuing Education Dean's Office Faculty & Institutional Affairs Fiscal Affairs Libraries Medical Education Research Student Affairs	Biochemistry & Molecular Biology Cell Biology & Anatomy Genetics Microbiology, Immunology & Parasitology Pharmacology Physiology	Anesthesiology Dermatology Family Medicine Internal Medicine Emergency Medicine Gastroenterology Physical Medicine & Rehabilitation Neurology Neurosurgery OB/GYN Ophthalmology Orthopaedics Otorhinolaryngology Pathology Pediatrics Psychiatry Radiology Surgery Urology	Alcohol and Drug Abuse Center Cardiovascular Center Center on Healthy Aging Center for Molecular and Human Genetics Epilepsy Center Eye Center Ernest N. Morial Asthma, Allergy, and Respiratory Disease Center Gene Therapy Program Low Vision Center Neurosciences Center The Research Institute For Children Stanley S. Scott Cancer Center

	Lala M. Dunbar, MD, PhD Major Emergency Room Director and Research Director Professor of Clinical Medicine 2021 Perdido Street 5th Floor Room 535W New Orleans, La. 70112 Phone 504-903-3594 Fax 504-903-4569 ldunba@lsuhsc.edu
Degrees	BS Chemistry - 1954 George Washington University, Washington, DC MS Biochemistry - 1969 George Washington University School of Medicine PhD Biochemistry - 1972 George Washington University School of Medicine MD - 1978 George Washington University School of Medicine
Research Interests	Metabolism of Omega-3 and Omega-6 Fatty Acids in Cultured Cells Evaluation of New Biochemical Markers Troponin T and Troponin I Aggressive ED Management of DKA Aggressive Management of Hypertension in the ED Management of Hyperglycemia in the ED Hyponatremia in Community Acquired Pneumonia Co-existence of Typical and Atypical Pathogens in Community Acquired Pneumonia
Selected Publications	Dunbar LM, Carbon C, Rensburg D, Tellier G, Rangaraju M and Nasrat R, Efficacy of Telithromycin in Community Acquired Pneumonia Caused by Atypical and Intracellular Pathogens., Infect Dis Clin Pract (submitted), July 2003. Dunbar L, Hassman J and Tellier G, Efficacy and Tolerability of Once Daily Oral Therapy with Telithromycin Compared with Clarithromycin for the Treatment of Community Acquired Pneumonia in Adults., Excerpta Medica (accepted), 2004. Dunbar LM, Wunderink RG, Habib MP, Smith LG, Tennenberg AM, Khashab MM, Wiesinger BA, Xiang JX, Zadeikis N, Kahn JB, High-dose, Short-course Levofloxacin for Community-acquired Pneumonia: A New Treatment Paradigm., CID 37:752-60, 2003. Hagberg L, Carbon C, van Rensburg DJ, Fogarty, Dunbar L, and Pullman J, Telithromycin in the treatment of community-acquired pneumonia: a pooled analysis., Respiratory Medicine Vol 97: 625-633, 2003. Fogarty CM. Greenberg RN, Dunbar L, Player R, Marrie TJ, Kojak CM, Morgan N, Williams RR, Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae: integrated results from four open-label, multicenter, Phase III clinical trials., Clin Ther 23(3) 425-39, 2001 Mar.
Additional Info	Curriculum Vitae

Major Emergency Room Director and Research DirectorProfessor of Clinical Medicine

Major Emergency Room Director and Research Director
Professor of Clinical Medicine